Wristwatch pulse wave monitoring: assessing daily activity post-catheter ablation for atrial fibrillation

被引:0
|
作者
Nonoguchi, Noriko Matsushita [1 ]
Soejima, Kyoko [1 ]
Katsume, Yumi [1 ]
Hoshida, Kyoko [1 ]
Togashi, Ikuko [2 ]
Goda, Ayumi [1 ]
Ueda, Akiko [2 ]
Matsuo, Seiichiro [1 ]
Sato, Toshiaki [2 ]
Takano, Yuichi [3 ]
Koyama, Fumio [3 ]
Fujita, Shin [3 ]
Nishimura, Kunihiro [4 ]
Kohno, Takashi [1 ]
机构
[1] Kyorin Univ Hosp, Dept Cardiovasc Med, 6-20-2 Shinkawa, Mitaka City, Tokyo 1818611, Japan
[2] Kyorin Univ, Sch Med, Div Adv Arrhythmia Management, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan
[3] Fujimi Plant Seiko Epson Corp, Core Technol Dev Dept, 281 Fujimi, Nagano 3990293, Japan
[4] Natl Cerebral & Cardiovasc Ctr Res Inst, 6-1 Kishibe Shinmachi, Suita, Osaka 5648565, Japan
来源
关键词
Daily activity; Catheter ablation; Atrial fibrillation; Wristwatch-type pulse wave monitor; Photoplethysmography; QUALITY-OF-LIFE; RADIOFREQUENCY ABLATION; EARLY RECURRENCE; BLANKING PERIOD; RISK; ASSOCIATION; ACCURACY; IMPACT;
D O I
10.1093/ehjdh/ztae091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Atrial fibrillation (AF) leads to impaired exercise capacity, and catheter ablation (CA) for AF improves exercise capacity. However, the precise changes in daily activities after CA for AF remain unclear. The authors aimed to evaluate the changes in daily activities following CA for AF using a wristwatch-type pulse wave monitor (PWM), which tracks steps and exercise time, estimates burnt daily calories, and records sleep duration, in addition to establishing the rhythm diagnosis of AF or non-AF. Methods and results One hundred and twenty-three patients with AF (97 paroxysmal, 26 persistent) wore a wristwatch-type PWM for 1 week duration at three time points: before, 1 month after, and 3 months after ablation. Daily activity data were compared. Steps did not change in both groups, and the number of burnt daily calories and total exercise time increased after CA in patients with paroxysmal AF (burnt daily calories: before, 1591 kcal/day; 1 month, 1688 kcal/day; and 3 months, 1624 kcal/day; P < 0.001 and exercise time: before, 45.8 min; 1 month, 51.2 min; and 3 months, 56.3 min; P = 0.023). Sleep hours significantly increased (paroxysmal AF: before, 6.8 h; 1 month, 7.1 h; and 3 months, 7.1 h; P = 0.039 and persistent AF: before, 6.0 h; 1 month, 7.0 h; and 3 months, 7.0 h; P = 0.007). Conclusion Using a wristwatch-type PWM, we demonstrated changes in daily activities after CA in patients with AF. Trial registration number jRCT1030210022.
引用
收藏
页码:96 / 103
页数:8
相关论文
共 50 条
  • [1] The Role of Colchicine in Treating Postoperative and Post-catheter Ablation Atrial Fibrillation
    Deftereos, Spyridon G.
    Vrachatis, Dimitrios A.
    Angelidis, Christos
    Vrettou, Agathi-Rosa
    Sarri, Eleni K.
    Giotaki, Sotiria G.
    Varytimiadi, Efthymia
    Kossyvakis, Charalampos
    Kotsia, Eleana
    Deftereos, Gerasimos S.
    Doudoumis, Konstantinos
    Giannopoulos, Georgios
    CLINICAL THERAPEUTICS, 2019, 41 (01) : 21 - 29
  • [2] Predictive Value of Supraventricular Tachycardia on Ambulatory ECG Monitoring for Recurrent Atrial Fibrillation Post-Catheter Ablation
    Sanadgol, Ghazal
    Ramadan, Adham
    Alfie, Tristan
    Yazdanpanah, Mohammad Hosein
    Nahlawi, Acile
    Ptaszek, Leon
    Ruskin, Jeremy
    CIRCULATION, 2024, 150
  • [3] A Retrospective Cohort Study on Predictors for Rehospitalizations With Recurrence of Atrial Fibrillation Post-Catheter Ablation for Atrial Fibrillation
    Shah, Farhan A.
    Mahler, Nathan
    Winkle, Sean M.
    Fujikawa, Priscilla
    Nader, Brandon
    Rodriguez, Juan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [4] Development and validation of a predictive model for atrial fibrillation recurrence post-catheter ablation in patients with nonvalvular atrial fibrillation on the basis of hemodynamic parameters
    Zeng, Decai
    Chang, Shuai
    Zhang, Xiaofeng
    Zhong, Yanfen
    Cai, Yongzhi
    Huang, Tongtong
    Wu, Ji
    HEART RHYTHM, 2025, 22 (04) : 900 - 913
  • [5] Safety and efficacy of colchicine for the prevention of recurrent atrial fibrillation post-catheter ablation Colchicine for Recurrent AF Post-PVI
    Agarwal, Siddharth
    Munir, Muhammad Bilal
    Asad, Zain Ul Abideen
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 111 : 143 - 145
  • [6] The efficacy of colchicine in preventing atrial fibrillation recurrence and pericarditis post-catheter ablation for atrial fibrillation - A systematic review and meta-analysis of prospective studies
    Borra, Vamsikalyan
    Mahadevan, Arankesh
    Senapati, Sidhartha Gautam
    Vempati, Roopeessh
    Jaiswal, Vikash
    Borra, Nithya
    Ahmad, Javaria
    Herrera, Oscar Rodrigo Zamudio
    Sanchez, Carlos Vergara
    Prasad, Tanisha
    Thachil, Rosy
    Ganatra, Sarju
    Dani, Sourbha
    IJC HEART & VASCULATURE, 2024, 53
  • [7] Atrial arrhythmia recurrence post-catheter ablation: when perfect is the enemy of good
    Al-Kaisey, Ahmed M.
    Kalman, Jonathan M.
    EUROPEAN HEART JOURNAL, 2023, 44 (09) : 777 - 779
  • [8] The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial
    Verma, Atul
    Ha, Andrew C. T.
    Kirchhof, Paulus
    Hindricks, Gerhard
    Healey, Jeff S.
    Hill, Michael D.
    Sharma, Mukul
    Wyse, D. George
    Champagne, Jean
    Essebag, Vidal
    Wells, George
    Gupta, Dhiraj
    Heidbuchel, Hein
    Sanders, Prashanthan
    Birnie, David H.
    AMERICAN HEART JOURNAL, 2018, 197 : 124 - 132
  • [9] Impedance monitoring during catheter ablation of atrial fibrillation
    Vaseghi, M
    Cesario, DA
    Valderrabano, M
    Boyle, NG
    Ratib, O
    Finn, JP
    Wiener, I
    Shivkumar, K
    HEART RHYTHM, 2005, 2 (09) : 914 - 920
  • [10] Sacubitril-Valsartan Lowers Atrial Fibrillation Recurrence and Left Atrial Volume Post-catheter Ablation: Systematic Review and Meta-Analysis
    de Lucena, Larissa Araujo
    Freitas, Marcos Aurelio Araujo
    Guida, Camila Mota
    Hespanhol, Larissa C.
    de Sousa, Ana Karenina C.
    de Sousa, Julio Cesar V.
    Maia, Ferdinand Gilbert S.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 157 - 167